News from boston scientific A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 01, 2015, 08:30 ET

Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second...

Jun 22, 2015, 09:00 ET

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the...

Jun 10, 2015, 09:00 ET

New Data Demonstrate Greater Pain Relief With Boston Scientific Precision Spectra™ Spinal Cord Stimulator System

Boston Scientific Corporation (NYSE: BSX) presented new data demonstrating  that the Precision Spectra™ Spinal Cord Stimulator (SCS)...

Jun 04, 2015, 09:00 ET

Boston Scientific Launches The Precision Novi™ Spinal Cord Stimulator System in Europe

Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International...

May 26, 2015, 08:30 ET

Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs 36th Annual Global Healthcare Conference on June 9 in...

May 20, 2015, 02:31 ET

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

A new study evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System demonstrated an extremely low rate of paravalvular aortic...

May 19, 2015, 07:52 ET

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

 Boston Scientific (NYSE: BSX) reported positive, long-term data from the EVOLVE Trial of the SYNERGY™ Everolimus-Eluting Bioabsorbable...

May 12, 2015, 10:53 ET

Boston Scientific Completes $1.85 Billion Senior Notes Offering

 Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.85 billion aggregate principal amount of its senior notes under...

May 11, 2015, 09:24 ET

Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2015

Boston Scientific (NYSE: BSX) today announced that key data from 42 abstracts will be featured at the 36th Annual Scientific Sessions of the...

May 07, 2015, 17:38 ET

Boston Scientific Prices $1.85 Billion Of Senior Notes

 Boston Scientific Corporation (NYSE: BSX) announced the pricing of a public offering of $1.85 billion aggregate principal amount of its senior...

May 01, 2015, 08:00 ET

Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day

 Boston Scientific Corporation (NYSE: BSX) is presenting an overview of its continued business momentum and long-term growth strategies at a...

Apr 30, 2015, 08:30 ET

Boston Scientific Collaborates With MedAxiom And TogetherMD To Bring Value Based Solutions To Healthcare Systems

Boston Scientific (NYSE: BSX) announces the signing of two strategic agreements to advance the company's efforts to bring value based solutions...

Apr 28, 2015, 12:47 ET
http://www.multivu.com/players/English/7223454-boston-scientific-eluvia-stent/gallery/image/0bdeec48-e390-4e91-b48b-58bc5204f038.HR.jpg

New Data Evaluating The Boston Scientific Eluvia(TM) Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

 In an important clinical advancement in the treatment of peripheral artery disease (PAD), a key trial evaluating the Boston Scientific (NYSE:...

Apr 28, 2015, 07:00 ET

Boston Scientific Announces Results for First Quarter 2015

 Boston Scientific Corporation (NYSE: BSX) generated sales of $1.768 billion during the first quarter ended March 31, 2015, compared to the...

Apr 27, 2015, 16:30 ET

Boston Scientific To Participate In The Bank Of America Merrill Lynch 2015 Healthcare Conference

 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2015 Healthcare Conference on May...

Apr 27, 2015, 16:15 ET

Boston Scientific Announces Strategic Collaboration With Brainlab AG

Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that...

Apr 24, 2015, 08:30 ET

Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 40th Annual Healthcare Conference on May 6 in...

Apr 20, 2015, 16:01 ET

Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific S-ICD™ System

Today the Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific...

Apr 16, 2015, 16:05 ET
In the U.S., the Vessix™ Renal Denervation System is an investigational device, limited by applicable law to investigational use and not available for sale.

Boston Scientific Enrolls First Patient In New Study Designed To Demonstrate The Effect Of The Vessix™ Renal Denervation System

 Boston Scientific Corporation (NYSE: BSX) is taking a new approach to evaluate the performance of the Vessix™ Renal Denervation...

Apr 14, 2015, 09:00 ET

Boston Scientific Signs Strategic Alliance With Frankenman Medical Equipment Company

Boston Scientific Corporation (NYSE: BSX), a leading global medical device company, announced the signing of a strategic alliance with Frankenman...